DiaMedica Therapeutics Inc

NASDAQ:DMAC   3:59:53 PM EDT
4.20
+0.01 (+0.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

DiaMedica Therapeutics Inc Stock, NASDAQ:DMAC

2 Carlson Parkway, Suite 260, Minneapolis, Minnesota 55447
Canada (Federal Level)
Phone: +1.763.312.6755
Number of Employees: 11

Description

DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.